EI
IONS icon

EFG International’s Ionis Pharmaceuticals IONS Stock Holding History

EFG International’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.74M Buy
122,804
+28,824
+31% +$2.17M 0.18% 97
2026
Q1 		$7.06M Buy
93,980
+18,704
+25% +$1.48M 0.15% 116
2025
Q4 		$5.96M Buy
+75,276
New +$5.67M 0.12% 151

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

EFG International's IONS Position: Q2 2026 in Review

EFG International increased its Ionis Pharmaceuticals (IONS) stake by 31% in Q2 2026, buying an estimated $2.17M and bringing the position to 122,804 shares worth $9.74M. The position accounts for 0.18% of the portfolio, ranked #97.

EFG International first reported a position in IONS in Q4 2025 and has held it in 3 quarters since. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • EFG International held 122,804 shares of Ionis Pharmaceuticals worth $9.74M as of Q2 2026.
  • EFG International bought 28,824 Ionis Pharmaceuticals shares in Q2 2026, an estimated $2.17M.
  • Ionis Pharmaceuticals made up 0.18% of EFG International's portfolio in Q2 2026, its #97 holding.
  • EFG International first reported a position in Ionis Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on EFG International's 13F filing for Q2 2026, filed 14 Aug 2026.